Inhibition of IκBα nuclear export as an approach to abrogate nuclear factor-κB-dependent cancer cell survival

Molecular Cancer Research

Volumn 3, Issue 1, 2005, Pages 42-49

  O'Connor, Shelby ^a   Shumway, Stuart ^a   Miyamoto, Shigeki ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL NUCLEUS; CELL SURVIVAL; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; ACTIVE TRANSPORT; ANIMAL; BIOLOGICAL MODEL; CELL CYCLE; CYTOPLASM; FIBROBLAST; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; METABOLISM; MOUSE; MUTAGENESIS; NEOPLASM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TIME; TRANSGENIC MOUSE; TUMOR CELL LINE; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MODELS, GENETIC; MUTAGENESIS; MUTAGENESIS, SITE-DIRECTED; NEOPLASMS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 13244273517     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;2:301-10.
2. Cox AD, Der CJ. The dark side of Ras: regulation of apoptosis. Oncogene 2003;22:8999-9006.
3. Reuther JY, Reuther GW, Cortez D, Pendergast AM, Baldwin AS Jr. A requirement for NF-κB; activation in Bcr-Abl-mediated transformation. Genes Dev 1998;12:968-81.
4. + cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 2004; 103:3175-84.
5. Patel NM, Nozaki S, Shortle NH, et al. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide. Oncogene 2000;19:4159-69.
6. Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN. Oncogene 2001;20:1287-99.
7. Gasparian AV, Yao YJ, Kowalczyk D, et al. The role of IKK in constitutive activation of NF-κB transcription factor in prostate carcinoma cells. J Cell Sci 2002;115:141-51.
8. Duffey DC, Chen Z, Dong G, et al. Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 1999;59:3468-74.
9. Voorhees PM, Dees EC, O'Neil B, Orlowski RZ. The proteasome as a target for cancer therapy. Clin Cancer Res 2003;9:6316-25.
10. Chiao PJ, Miyamoto S, Verma IM. Autoregulation of IκBα activity. Proc Natl Acad Sci U S A 1994;91:28-32.
11. Arenzana-Seisdedos F, Turpin P, Rodriguez M, et al. Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm. J Cell Sci 1997;110:369-78.
12. Huang TT, Miyamoto S. Postrepression activation of NF-κ requires the amino-terminal nuclear export signal specific to IκBα. Mol Cell Biol 2001; 21:4737-47.
13. Huang TT, Kudo N, Yoshida M, Miyamoto S. A nuclear export signal in the N-terminai regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes. Proc Natl Acad Sci U S A 2000;97:1014-9.
14. Johnson C, Van Antwerp D, Hope TJ. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα. EMBO J 1999; 18:6682-93.
15. Komiyama K, Okada K, Tomisaka S, Umezawa I, Hamamoto T, Beppu T. Antitumor activity of leptomycin B. J Antibiot (Tokyo) 1985;38:427-9.
16. O'Connor S, Shumway SD, Amanna IJ, Hayes CE, Miyamoto S. Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IκBα degradation in B cells. Mol Cell Biol 2004;24:4895-908.
17. Jungnickel B, Staratschek-Jox A, Brauninger A, et al. Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 2000;191:395-402.
18. Suyang H, Phillips R, Douglas I, Ghosh S. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB. Mol Cell Biol 1996;16: 5444-9.
19. Miyamoto S, Seufzer BJ, Shumway SD. Novel IκBα proteolytic pathway in WEHI231 immature B cells. Mol Cell Biol 1998;18:19-29.
20. Malek S, Huxford T, Ghosh G. IκBα functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-κB. J Biol Chem 1998;273:25427-35.
21. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001;194:1861-74.
22. Dobrzanski P, Ryseck RP, Bravo R. Differential interactions of Rel-NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity. EMBO J 1994;13:4608-16.
23. Yoshida M, Horinouchi S. Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export. Ann N Y Acad Sci 1999;886:23-36.
24. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996;274:782-4.
25. Newlands ES, Rustin GJ, Brampton MH. Phase I trial of elactocin. Br J Cancer 1996;74:648-9.
26. Inoue J, Kerr LD, Ransone LJ, Bengal E, Hunter T, Verma IM. c-rel activates but v-rel suppresses transcription from κB sites. Proc Natl Acad Sci U S A 1999;88:3715-9.
27. Miyamoto S, Schmitt MJ, Verma IM. Qualitative changes in the subunit composition of κB-binding complexes during murine B-cell differentiation. Proc Natl Acad Sci U S A 1994;91:5056-60.
28. Van Antwerp DJ, Verma IM. Signal-induced degradation of I(κ)B(α): association with NF-κB and the PEST sequence in I(κ)B(α) are not required. Mol Cell Biol 1996;16:6037-45.
29. Miyamoto S, Chiao PJ, Verma IM. Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol Cell Biol 1994;14:3276-82.
30. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.